Account
Taboola signs three-year strategic partnership with dentsu India
Mumbai: Content discovery and native advertising platform Taboola has announced a three-year strategic partnership with dentsu India, a multinational media and digital marketing communications network, headquartered in London, UK.
Under the partnership, dentsu India will leverage Taboola’s offerings to reach consumers at scale across premium editorial sites. and also support brand awareness and acquisition goals, said the company in a statement on Monday.
“Our objective has been to create maximum value for our clients,” said dentsu Media South Asia CEO Divya Karani. “We are pleased to partner with Taboola towards this and leverage its expertise to drive new avenues of growth, increase engagement. We are certain that with Taboola, we will be able to optimise audience engagements and explore new frontiers of transformation for the digital consumers of today.”
The network will use Taboola’s several advertiser offerings across its entire customer portfolio. These include multinational companies that work with its huge media agency network, spanning over retail, automotive, CPG, consumer electronics, and more, said the statement.
Taboola Video will empower dentsu India to engage with audiences through high-visibility placements across premium editorial sites through its publisher network that reaches 500 million daily active users, it added.
“We are honoured to have secured the long-term trust of its agencies and their impressive list of brand customers. We look forward to working side-by-side with dentsu India to help its customers reach consumers through our massive network, build creative strategies, and scale,” said Taboola CEO and founder Adam Singolda.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
